REGN
REGENERON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$930.67
−4.39%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.03x
- Debt / assets
- 0.06x
- Debt / EBITDA
- 0.43x
- Net debt / EBITDA
- -0.15x
Liquidity & coverage
- Current ratio
- 3.35x
- Quick ratio
- 2.89x
- Cash ratio
- 1.50x
- Interest coverage
- 106.88x
- EBITDA / interest
- 133.76x
- Working capital
- $14.6B
Cash & dividend
- FCF / debt
- 1.33x
- Cash flow / debt
- 1.70x
- Dividend per share
- $3.70
- Dividend yield
- 0.4%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026